DOCK2 Deficiency Diagnosed 18 Years After Hematopoietic Stem Cell Transplantation
Katherine D'Astous-Gauthier1, Aléhandra Desjardins2,3, Louis Marois4,5
1Department of Pediatric, Clinical Immunology and Allergy, University of Sherbrooke, Sherbrooke, QC, Canada.
Journal of Clinical Immunology
|April 30, 2021
Abstract
No abstract available in PubMed .
Related Concept Videos
Bone Marrow Sampling and Transplants
620
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
620
Multipotency of Hematopoietic Stem Cells
3.5K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.5K


